5.92
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché WVE Giù?
Forum
Previsione
Wave Life Sciences Ltd Borsa (WVE) Ultime notizie
WAVE Life Sciences Ltd (WVE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
WAVE Life Sciences Ltd (WVE) Cash Flow - TradingKey
WAVE Life Sciences Ltd (WVE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
WVE|WAVE Life Sciences Ltd|Price:5.810|Chg%:+0.030 - TradingKey
TradingKey - TradingKey
Wave Life Sciences Ltd. Revenue Breakdown – NASDAQ:WVE - TradingView
WVE Stock Edges Up After Positive Early Data For Rare Disease Drug - Stocktwits
WAVE Life Sciences Ltd (WVE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
What Went Wrong For WVE? The Obesity Drug Trial Data That Spooked Investors - Stocktwits
Is Analyst Upgrade After Q2 Review Altering The Investment Case For Wave Life Sciences (WVE)? - simplywall.st
Wave Life Sciences (WVE) Stock Looks Cheap On Price But Expensive On Sales - Yahoo Finance
Trading the Move, Not the Narrative: (WVE) Edition - Stock Traders Daily
Wave Life Sciences to report Q2 2026 financial results on July 30 - scanx.trade
Wave Life Sciences stock trades steady as genetic medicine pipeline advances after recent loss narro - Ad-hoc-news.de
Wave Life Sciences to Host Second Quarter 2026 Financial Results Webcast and Conference Call - Quiver Quantitative
Wave Life Sciences Second Quarter 2026 Financial Results Scheduled for July 30, 2026 - The Manila Times
Wave Life Sciences Ltd (WVE) News, Articles, Events & Latest Updates - Stocktwits
Wave Life Sciences to host webcast, call on second-quarter results - Bitget
Wave Life Sciences (WVE) Upgraded to Strong Buy: What Does It Mean for the Stock? - Yahoo Finance Singapore
New Strong Buy Stocks for July 22nd - The Globe and Mail
Is Wave Life Sciences (WVE) Undervalued Or Is Its RNA Pipeline Already Priced In? - simplywall.st
Wave Life Sciences Ltd. (WVE) Stock Analysis: Unveiling a Potential 282.85% Upside in Biotech - DirectorsTalk Interviews
Wave Life Sciences Pte. Ltd (WVE) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
WAVE LIFE SCIENCES LTD (WVE) Stock Chart - ChartMill
Wave Life Sciences Pte. Ltd (WVE) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks
ETFs Investing in Wave Life Sciences Ltd. Stocks - TradingView
WVE Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
WVE Technical Analysis & Stock Price Forecast - Intellectia AI
ARWR Stock Slid Lower Today — What Does Wave Life Sciences Have To Do With It? - Stocktwits
Has Wave Life Sciences (WVE) Fallen Far Enough To Look Fairly Valued? - Sahm
Wave Life Sciences (WVE) 44th Annual J.P. Morgan Healthcare Conference Summary - Quartr
Wave Life Sciences court hearing set for July 14 on redomiciliation - Investing.com
Wave Life Sciences court hearing set for July 14 on redomiciliation By Investing.com - Investing.com South Africa
Wave Life Sciences Announces Singapore Court Hearing, to be held on July 14, 2026 to Approve Scheme of Arrangement for Redomiciliation - The Manila Times
Press Release: Wave Life Sciences Announces Singapore Court Hearing, to Be Held on July 14, 2026 to Approve Scheme of Arrangement for Redomiciliation - Moomoo
Wave Life Sciences (WVE) Is Up 7.4% After Advancing RNA-Based Obesity Drug Into Phase 2a Trial - simplywall.st
Is Wave Life Sciences (WVE) Undervalued On Its New Obesity Trial Progress? - simplywall.st
Does Wave Life Sciences (WVE) Have the Potential to Rally 294.66% as Wall Street Analysts Expect? - Yahoo Finance
Jessica Chen - White & Case LLP
(WVE) Volatility Zones as Tactical Triggers - Stock Traders Daily
Wave Life Sciences (WVE) Initiates Multidose Phase 2a for INLIGHTTM Trial - Insider Monkey
Price to earnings forward of Wave Life Sciences Ltd. – NASDAQ:WVE - TradingView
7 Singapore Companies That Have Listed On Nasdaq And Where They Are Now - DollarsAndSense.sg
Does Wave Life Sciences’ (WVE) RNA Obesity Program Signal a Shift in Its Competitive Positioning? - simplywall.st
Enterprise value to EBITDA forward of Wave Life Sciences Ltd. – NASDAQ:WVE - TradingView
Price to sales forward of Wave Life Sciences Ltd. – NASDAQ:WVE - TradingView
Enterprise value to EBIT forward of Wave Life Sciences Ltd. – NASDAQ:WVE - TradingView
Price to book forward of Wave Life Sciences Ltd. – NASDAQ:WVE - TradingView
Price to book forward of Wave Life Sciences Ltd. – DUS:1U5 - TradingView
Wave Life Sciences (WVE) shareholders approve Singapore Scheme for redomiciliation - Stock Titan
We Think Wave Life Sciences (NASDAQ:WVE) Can Afford To Drive Business Growth - Moomoo
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):